Publication Name	World Journal of Transplantation
Manuscript ID	26932
Country	China

Received	2016-04-29 17:17
Peer-Review Started	2016-05-03 11:04
First Decision by Editorial Office Director
Return for Revision	2016-06-17 16:23
Revised	2016-06-26 10:49
Publication Fee Transferred
Second Decision by Editor	2016-08-08 15:30
Second Decision by Editor-in-Chief	2016-08-08 17:33
Final Decision by Editorial Office Director	2016-08-18 11:53
Articles in Press	2016-08-18 11:53
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-09-18 21:32
Publish the Manuscript Online	2016-09-23 15:41

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Updates on antibody-mediated rejection in intestinal transplantation
Manuscript Source	Invited Manuscript
All Author List	Guo-Sheng Wu
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81570588
Corresponding Author	Guo-Sheng Wu, MD, PhD, Division of Gastrointestinal Surgery, Xijing Hospital of Digestive Diseases, the Fourth Military Medical University, #127 Changle West Rd, Xi’an 710032, Shannxi Province, China. guosheng_w@yahoo.com
Key Words	Intestinal transplantation; Antibody-medi­ated rejection; Hyperacute rejection; Chronic rejec­tion; Donor-specific antibodies; C4d deposition; Outcomes
Core Tip	Antibody-mediated rejection (ABMR) has increasingly surfaced as an important cause of allograft loss after intestinal transplantation. The presence of donor-specific antibodies (DSAs) should alert the clinician of the increased risk of ABMR. The avoidance of a known donor-specific antibody target at the time of transplant remains a primary preventive strategy. The development of newly-formed DSAs usually portends a poor prognosis with an increased risk of refractory acute rejection, chronic rejection, and allograft loss. The better understanding of mechanisms of antibody-mediated graft injury, establishment of the diagnostic criteria, and optimal management of these antibodies may improve clinical outcomes of intestine transplants.
Publish Date	2016-09-23 15:41
Citation	Wu GS. Updates on antibody-mediated rejection in intestinal transplantation. World J Transplant 2016; 6(3): 564-572
URL	http://www.wjgnet.com/2220-3230/full/v6/i3/564.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i3.564

Full Article (PDF)	WJT-6-564.pdf
Full Article (Word)	WJT-6-564.doc
Manuscript File	26932-Review.docx
Answering Reviewers	26932-Answering reviewers.pdf
Audio Core Tip	26932-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26932-Conflict-of-interest statement.pdf
Copyright License Agreement	26932-Copyright assignment.pdf
Peer-review Report	26932-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26932-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26932-Scientific misconduct check.pdf
Scientific Editor Work List	26932-Scientific editor work list.pdf